2019
Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization
Schobert I, Chapiro J, Nezami N, Hamm CA, Gebauer B, Lin M, Pollak J, Saperstein L, Schlachter T, Savic LJ. Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization. Journal Of Nuclear Medicine 2019, 60: 1066-1072. PMID: 30655331, PMCID: PMC6681698, DOI: 10.2967/jnumed.118.219691.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngiographyBiomarkersCarcinoma, HepatocellularEmbolization, TherapeuticFeasibility StudiesFemaleHumansImaging, Three-DimensionalLiverLiver NeoplasmsMagnetic Resonance ImagingMaleMicrospheresMiddle AgedMultimodal ImagingPrognosisRegression AnalysisRetrospective StudiesTomography, Emission-Computed, Single-PhotonTomography, X-Ray ComputedTreatment OutcomeYttrium RadioisotopesConceptsNon-HCC patientsTransarterial radioembolizationHepatocellular carcinomaBaseline imagingTumor responseTumor volumeChild-Pugh class B patientsBaseline imaging featuresClass B patientsNormal liver ratiosTotal tumor volumeSPECT/CTContrast-enhanced MRIQuantitative European AssociationMultiphasic contrast-enhanced MRIInstitutional review boardHigh TNRPreprocedural MRIChild-PughB patientsLiver criteriaTumor burdenClinical parametersHepatic malignanciesRetrospective study
2013
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Tacher V, Lin M, Bhagat N, Jaoudeh N, Radaelli A, Noordhoek N, Carelsen B, Wood B, Geschwind J. Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization. Journal Of Visualized Experiments 2013, 50795. PMID: 24326874, PMCID: PMC3910428, DOI: 10.3791/50795.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaDP-CBCTDual phase CBCTDrug-eluting beadsCone-Beam Computed TomographyRole of CBCTMagnetic resonance imagingDEB-TACETreatment successInvasive therapyLiver tumorsComputed tomographyHCC treatmentInterventional radiologyResonance imagingAngiography suiteDiagnostic imagingSelective therapyCone beamDiagnostic accuracyCBCT techniqueInterventional suiteCarcinomaCBCTTherapy
2011
Comparing the Detectability of Hepatocellular Carcinoma by C-Arm Dual-Phase Cone-Beam Computed Tomography During Hepatic Arteriography With Conventional Contrast-Enhanced Magnetic Resonance Imaging
Loffroy R, Lin M, Rao P, Bhagat N, Noordhoek N, Radaelli A, Blijd J, Geschwind J. Comparing the Detectability of Hepatocellular Carcinoma by C-Arm Dual-Phase Cone-Beam Computed Tomography During Hepatic Arteriography With Conventional Contrast-Enhanced Magnetic Resonance Imaging. CardioVascular And Interventional Radiology 2011, 35: 97-104. PMID: 21328023, DOI: 10.1007/s00270-011-0118-x.Peer-Reviewed Original ResearchConceptsHCC lesionsMagnetic resonance imagingHepatocellular carcinomaHepatic arteriographyVenous phaseArterial phaseDrug-Eluting Beads Transarterial ChemoembolizationCE-MRIResonance imagingContrast-enhanced magnetic resonance imagingGold standardResultsSeventy-sevenTransarterial chemoembolizationHCC nodulesTerms of conspicuitySufficient image qualityTumorsDiagnostic imagingLesionsArteriographyCE-MR imagesCarcinomaLiverTomographyImaging